Search clinical trials for: irofulven
Total 21 results
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States, Canada
-
New Approaches to Brain Tumor Therapy ConsortiumNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedGastric CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada, Australia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
The University of Texas Health Science Center at...National Cancer Institute (NCI); Merck Sharp & Dohme LLC; University of TexasCompletedPancreatic CancerUnited States
-
University of Colorado, DenverNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
University of ChicagoNational Cancer Institute (NCI)WithdrawnColorectal CancerUnited States
-
Eisai Inc.CompletedThyroid CancerUnited States, France, Ukraine, Peru, Russian Federation, Argentina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
Eisai Inc.Completed
-
University of PrimorskaComenius University; Ludwig Boltzmann Institute of Electrical Stimulation and... and other collaboratorsCompleted
-
Eisai Inc.CompletedPancreatic CancerUnited States
-
Allarity TherapeuticsSmerud Medical Research International AS; Lantern Pharma Inc.Active, not recruitingIrofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)Metastatic Castration-Resistant Prostate Cancer PatientsDenmark
-
Eisai Inc.CompletedProstate CancerFrance, United States, Romania, Canada, Peru, Brazil, Russian Federation, Chile, Croatia